BRAF Inhibition in Congenital Nevi and Neural Melanosis

This case report describes sustained neurologic and cutaneous improvement following BRAF inhibition in a patient with V600E–variant neurocutaneous melanosis.

Corresponding Author: Vijay Ramaswamy, MD, PhD, Division of Haematology/Oncology, The Hospital for Sick Children, 17-9705 PGCRL, 686 Bay St, Toronto, ON M5G 0A4, Canada (vijay.ramaswamy@sickkids.ca).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.